Visiomed Group SA
PAR:ALVMG

Watchlist Manager
Visiomed Group SA Logo
Visiomed Group SA
PAR:ALVMG
Watchlist
Price: 0.1726 EUR -1.82% Market Closed
Market Cap: 53.1m EUR
Have any thoughts about
Visiomed Group SA?
Write Note

Net Margin
Visiomed Group SA

6.6%
Current
-188%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.6%
=
Net Income
902k
/
Revenue
13.7m

Net Margin Across Competitors

Country FR
Market Cap 50.8m EUR
Net Margin
7%
Country US
Market Cap 199.4B USD
Net Margin
14%
Country US
Market Cap 190.5B USD
Net Margin
29%
Country US
Market Cap 139.9B USD
Net Margin
16%
Country US
Market Cap 133.6B USD
Net Margin
11%
Country IE
Market Cap 103.6B USD
Net Margin
13%
Country US
Market Cap 66B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.6B USD
Net Margin
74%
Country CN
Market Cap 313.1B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Visiomed Group SA
Glance View

Market Cap
50.8m EUR
Industry
Health Care

Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

ALVMG Intrinsic Value
0.387 EUR
Undervaluation 55%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.6%
=
Net Income
902k
/
Revenue
13.7m
What is the Net Margin of Visiomed Group SA?

Based on Visiomed Group SA's most recent financial statements, the company has Net Margin of 6.6%.